Molecular allergy testing is the future of in vitro allergy diagnostics. Thermo Fisher Scientific required a means to clearly communicate the clinical and economic benefits of this new technology to support reimbursement discussions at the national and hospital level.
Normally, an economic model has little value to the marketing and sales teams before it is published. Using the app we’ve been able to disseminate this information earlier. It bridges the gap between when the material is produced and when a publication is available. — Lisse-Lotte Hermansson, Director Health Economics for Global Marketing